Citation: | BIANYong, ZHANGWen, SHILe, YUBin, YUYun, CUIWei-wei. Effect of Jasminoidin on Differentiation and Function of Treg Cells and Its Mechanism[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(6): 676-681. |
[1] |
史永平, 孔浩天, 李昊楠, 等. 栀子的化学成分、药理作用研究进展及质量标志物预测分析[J]. 中草药, 2019,50(2): 281-289.
|
[2] |
俞云, 时乐, 喻斌, 等. 栀子苷对类风湿性关节炎大鼠Th17/Treg平衡和局部炎症因子的影响[J]. 南京中医药大学学报, 2018, 34(5): 73-77.
|
[3] |
FANTINI MC, DOMINITZKI S, RIZZO A, et al. In vitro<\i> generation of CD4+ CD25+ regulatory cells from murine naive T cells[J]. Nat Protoc, 2007, 2(7): 1789-1794.
|
[4] |
GIZINSKI AM, FOX DA. T cell subsets and their role in the pathogenesis of rheumatic disease[J]. Curr Opin Rheumatol, 2014, 26(2): 204-210.
|
[5] |
饶桂华,钮晓音.PGE_2调节CD4+T细胞分化的研究进展[J]. 现代免疫学, 2017,37(1): 55-58.
|
[6] |
李佩容,危蓉,吴志平.Th17/Treg 细胞及其相关细胞因子在溃疡性结肠炎发病中的作用及其研究进展[J]. 世界科技研究与发展, 2017, 39(2): 194-197.
|
[7] |
FONTENOT JD, RASMUSSEN JP, WILLIAM LM, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3[J]. Immunity, 2005, 22(3): 329-341.
|
[8] |
WANG X, TOURNIER C. Regulation of cellular functions by the ERK5 signalling pathway[J]. Cell Signal, 2006, 18(6): 753-760.
|
[9] |
WANG T, SEAH S, LOH X, et al. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway[J]. Oncotarget, 2016, 7(3): 2532-2544.
|
[10] |
RUBINFELD H, SEGER R. The ERK cascade: A prototype of MAPK signaling[J]. Mol Biotechnol, 2005, 31(2): 151-174.
|
[11] |
GUPTA A, HOSSAIN MM, MILLER N, et al. NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2alpha-ATF4 signalling in breast cancer[J]. Oncogene, 2016, 35(45): 5860-5871.
|
[12] |
BOGOYEVITCH MA, KOBE B. Uses for JNK: The many and varied substrates of the c-Jun N-terminal kinases[J]. Microbiol Mol Biol Rev, 2006, 70(4): 1061-1095.
|
[13] |
SABAPATHY K. Role of the JNK pathway in human diseases[J]. Prog Mol Biol Transl Sci,2012,106:145-169.
|